Stay updated on Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Sign up to get notified when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.

Latest updates to the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page
- Check4 days agoChange DetectedA notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the ClinicalTrials.gov study record page.SummaryDifference1%

- Check11 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1; the page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThere are no additions or deletions to report for this page based on the provided data.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now shows a 403 Forbidden error with a minimal HTML header, replacing the typical study details. The additions include the '403' label, a short DOCTYPE/HTML snippet, a 'Home' link, and a 'Revision: v3.7.0' note.SummaryDifference17%

- Check59 days agoChange DetectedThe site’s revision number was updated from v3.6.5 to v3.6.6, indicating a behind-the-scenes deployment.SummaryDifference0.0%

Stay in the know with updates to Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors
Enter your email address, and we'll notify you when there's something new on the Precision 1 Clinical Trial: Nab-sirolimus in TSC1/TSC2 Gene Tumors page.